Hormuzd A Katki

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management
    Hormuzd A Katki
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health DHHS, Bethesda, MD 20892, USA
    J Low Genit Tract Dis 17:S78-84. 2013
  2. pmc Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines
    Hormuzd A Katki
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health DHHS, Bethesda, MD 20892, USA
    J Low Genit Tract Dis 17:S28-35. 2013
  3. pmc Follow-up testing after colposcopy: five-year risk of CIN 2+ after a colposcopic diagnosis of CIN 1 or less
    Hormuzd A Katki
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health DHHS, Bethesda, MD 20892, USA
    J Low Genit Tract Dis 17:S69-77. 2013
  4. pmc Five-year risks of CIN 3+ and cervical cancer among women with HPV testing of ASC-US Pap results
    Hormuzd A Katki
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health DHHS, Bethesda, MD 20892, USA
    J Low Genit Tract Dis 17:S36-42. 2013
  5. pmc Five-year risks of CIN 2+ and CIN 3+ among women with HPV-positive and HPV-negative LSIL Pap results
    Hormuzd A Katki
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health DHHS, Bethesda, MD 20892, USA
    J Low Genit Tract Dis 17:S43-9. 2013
  6. pmc Five-year risks of CIN 3+ and cervical cancer among women with HPV-positive and HPV-negative high-grade Pap results
    Hormuzd A Katki
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health DHHS, Bethesda, MD 20892, USA
    J Low Genit Tract Dis 17:S50-5. 2013
  7. pmc Five-year risks of CIN 3+ and cervical cancer among women who test Pap-negative but are HPV-positive
    Hormuzd A Katki
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health DHHS, Bethesda, MD 20892, USA
    J Low Genit Tract Dis 17:S56-63. 2013
  8. pmc Five-year risk of CIN 3+ to guide the management of women aged 21 to 24 years
    Hormuzd A Katki
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health DHHS, Bethesda, MD 20892, USA
    J Low Genit Tract Dis 17:S64-8. 2013
  9. pmc Estimating the agreement and diagnostic accuracy of two diagnostic tests when one test is conducted on only a subsample of specimens
    Hormuzd A Katki
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA
    Stat Med 31:436-48. 2012
  10. pmc Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice
    Hormuzd A Katki
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, DHHS, Bethesda, MD 20882, USA
    Lancet Oncol 12:663-72. 2011

Detail Information

Publications53

  1. pmc Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management
    Hormuzd A Katki
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health DHHS, Bethesda, MD 20892, USA
    J Low Genit Tract Dis 17:S78-84. 2013
    ..It is not clear how many negative posttreatment Pap or cotest results are needed to ensure adequate safety against CIN 2+ before returning to extended retesting intervals...
  2. pmc Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines
    Hormuzd A Katki
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health DHHS, Bethesda, MD 20892, USA
    J Low Genit Tract Dis 17:S28-35. 2013
    ..To promote management that is consistent with accepted practice, new guidelines incorporating cotesting should aim to achieve equal management of women at equal risk of cervical intraepithelial neoplasia grade 3 and cancer (CIN 3+)...
  3. pmc Follow-up testing after colposcopy: five-year risk of CIN 2+ after a colposcopic diagnosis of CIN 1 or less
    Hormuzd A Katki
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health DHHS, Bethesda, MD 20892, USA
    J Low Genit Tract Dis 17:S69-77. 2013
    ..An important question is how many subsequent negative Pap results, or negative Pap and human papillomavirus (HPV) cotest results, are needed before returning to an extended retesting interval...
  4. pmc Five-year risks of CIN 3+ and cervical cancer among women with HPV testing of ASC-US Pap results
    Hormuzd A Katki
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health DHHS, Bethesda, MD 20892, USA
    J Low Genit Tract Dis 17:S36-42. 2013
    ..However, despite ample data, the routine clinical performance of HPV testing of women with ASC-US has not been adequately documented...
  5. pmc Five-year risks of CIN 2+ and CIN 3+ among women with HPV-positive and HPV-negative LSIL Pap results
    Hormuzd A Katki
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health DHHS, Bethesda, MD 20892, USA
    J Low Genit Tract Dis 17:S43-9. 2013
    ..Some authors have suggested that HPV triage might be effective at older ages, when the percentage of HPV positivity among women with LSIL declines...
  6. pmc Five-year risks of CIN 3+ and cervical cancer among women with HPV-positive and HPV-negative high-grade Pap results
    Hormuzd A Katki
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health DHHS, Bethesda, MD 20892, USA
    J Low Genit Tract Dis 17:S50-5. 2013
    ..We examined whether HPV testing provides useful risk stratification in this context...
  7. pmc Five-year risks of CIN 3+ and cervical cancer among women who test Pap-negative but are HPV-positive
    Hormuzd A Katki
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health DHHS, Bethesda, MD 20892, USA
    J Low Genit Tract Dis 17:S56-63. 2013
    ..However, the performance of these guidelines in routine clinical practice has not been evaluated...
  8. pmc Five-year risk of CIN 3+ to guide the management of women aged 21 to 24 years
    Hormuzd A Katki
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health DHHS, Bethesda, MD 20892, USA
    J Low Genit Tract Dis 17:S64-8. 2013
    ..To inform the management of Pap test abnormalities among women aged 21 to 24 years, who have extremely low cancer risks, we compared risks of CIN 3+ among women aged 21 to 24 versus 25 to 29 years or 30 to 64 years...
  9. pmc Estimating the agreement and diagnostic accuracy of two diagnostic tests when one test is conducted on only a subsample of specimens
    Hormuzd A Katki
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA
    Stat Med 31:436-48. 2012
    ..To help promote subsampling designs, our R package CompareTests computes all of our agreement and diagnostic accuracy statistics...
  10. pmc Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice
    Hormuzd A Katki
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, DHHS, Bethesda, MD 20882, USA
    Lancet Oncol 12:663-72. 2011
    ....
  11. pmc Multiple diseases in carrier probability estimation: accounting for surviving all cancers other than breast and ovary in BRCAPRO
    Hormuzd A Katki
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Rockville, MD 20852 4910, USA
    Stat Med 27:4532-48. 2008
    ....
  12. pmc Incorporating medical interventions into carrier probability estimation for genetic counseling
    Hormuzd A Katki
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, 6120 Executive Blvd, Room 8044 Rockville, MD 20852, USA
    BMC Med Genet 8:13. 2007
    ..Mendelian models should account for medical interventions because interventions modify mutation penetrances and thus affect the carrier probability estimate...
  13. ncbi request reprint Assessing uncertainty in reference intervals via tolerance intervals: application to a mixed model describing HIV infection
    Hormuzd A Katki
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS 6120 Executive Blvd, Rockville, MD 20852 4910, USA
    Stat Med 24:3185-98. 2005
    ..The Bayesian formulation naturally overcomes some important limitations of the likelihood model...
  14. pmc Effect of misreported family history on Mendelian mutation prediction models
    Hormuzd A Katki
    Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, USA
    Biometrics 62:478-87. 2006
    ..We apply the results to the BRCAPRO model, which predicts the risk of carrying a mutation in the breast and ovarian cancer genes BRCA1 and BRCA2...
  15. pmc Circulating inflammation markers and prospective risk for lung cancer
    Meredith S Shiels
    Affiliations of authors Infections and Immunoepidemiology Branch MSS, AH, EAE, JK, AKC, Biostatistics Branch RMP, HAK, and Genetic Epidemiology Branch NEC, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD HPV Immunology Laboratory, SAIC Frederick Inc, Frederick, MD TJK, gs, LAP Department of Statistics, Dongguk University, Seoul, Korea J HP
    J Natl Cancer Inst 105:1871-80. 2013
    ..Despite growing recognition of an etiologic role for inflammation in lung carcinogenesis, few prospective epidemiologic studies have comprehensively investigated the association of circulating inflammation markers with lung cancer...
  16. pmc Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease
    Anil K Chaturvedi
    Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Blvd, EPS 7072 Rockville, MD 20852, USA
    J Infect Dis 203:910-20. 2011
    ..We investigated coinfection patterns for 25 human papillomavirus (HPV) types and assessed the risk conferred by multiple HPV types toward cervical disease...
  17. pmc Prevalence of and risk factors for oral human papillomavirus among young women in Costa Rica
    Krystle A Lang Kuhs
    National Cancer Institute, National Institutes of Health, Bethesda, Maryland
    J Infect Dis 208:1643-52. 2013
    ..Little is known about the epidemiology of oral human papillomavirus (HPV) in Latin America...
  18. pmc C-reactive protein and risk of lung cancer
    Anil K Chaturvedi
    Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Blvd, Rockville, MD 20852, USA
    J Clin Oncol 28:2719-26. 2010
    ..We investigated the association of circulating high-sensitivity C-reactive protein (CRP, an inflammation biomarker) and CRP single nucleotide polymorphisms (SNPs) with prospective lung cancer risk...
  19. pmc Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer
    Sharon R Pine
    Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892 4258, USA
    J Natl Cancer Inst 103:1112-22. 2011
    ..Previous studies that were based primarily on small numbers of patients suggested that certain circulating proinflammatory cytokines may be associated with lung cancer; however, large independent studies are lacking...
  20. pmc Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial
    Aimee R Kreimer
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Lancet Oncol 12:862-70. 2011
    ..Human papillomavirus (HPV) 16 and 18 infections cause most cases of anal cancer. We assessed efficacy of an AS04-adjuvanted HPV 16 and HPV 18 vaccine against anal infection with HPV 16, HPV 18, or both (HPV 16/18)...
  21. pmc Prevalence of and risk factors for anal human papillomavirus infection among young healthy women in Costa Rica
    Felipe A Castro
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    J Infect Dis 206:1103-10. 2012
    ..Anal cancer is caused by human papillomavirus (HPV), yet little is known about anal HPV infection among healthy young women...
  22. pmc Comparison of algorithm-based estimates of occupational diesel exhaust exposure to those of multiple independent raters in a population-based case-control study
    Melissa C Friesen
    Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, DHHS, Bethesda, MA, USA
    Ann Occup Hyg 57:470-81. 2013
    ....
  23. doi request reprint A general binomial regression model to estimate standardized risk differences from binary response data
    Stephanie A Kovalchik
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, U S A
    Stat Med 32:808-21. 2013
    ..The LEXPIT model found an increased risk due to abnormal Pap test in human papillomavirus-negative that was not detected with logistic regression. Our R package blm provides free and easy-to-use software for fitting the LEXPIT model...
  24. pmc Targeting of low-dose CT screening according to the risk of lung-cancer death
    Stephanie A Kovalchik
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, and Information Management Services, Rockville, MD, USA
    N Engl J Med 369:245-54. 2013
    ..It is not known whether the benefits and potential harms of such screening vary according to lung-cancer risk...
  25. pmc Comparison of two PCR-based human papillomavirus genotyping methods
    Philip E Castle
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, Room 5004, EPS MSC 7234, Bethesda, MD 20892 7234
    J Clin Microbiol 46:3437-45. 2008
    ..Both approaches are suitable for monitoring the impact of HPV16/18 vaccines in clinical trials...
  26. ncbi request reprint Breast-cancer risk in BRCA-mutation-negative women from BRCA-mutation-positive families
    Hormuzd A Katki
    Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
    Lancet Oncol 8:1042-3. 2007
  27. pmc Divergent estrogen receptor-positive and -negative breast cancer trends and etiologic heterogeneity in Denmark
    William F Anderson
    DHHS NIH National Cancer Institute Division of Cancer Epidemiology and Genetics Biostatistics Branch, Bethesda, MD, USA
    Int J Cancer 133:2201-6. 2013
    ..Divergent ER-specific trends are consistent with distinct etiologic pathways. If trends in known risk factors are responsible, the Danish and US experience may foreshadow a common pattern worldwide. ..
  28. ncbi request reprint Viral determinants of human papillomavirus persistence following loop electrical excision procedure treatment for cervical intraepithelial neoplasia grade 2 or 3
    Aimee R Kreimer
    Division of Cancer Prevention, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA
    Cancer Epidemiol Biomarkers Prev 16:11-6. 2007
    ..Data from Atypical Squamous Cells of Undetermined Significance-Low-Grade Squamous Intraepithelial Lesion Triage Study were used to evaluate HPV persistence and reappearance after LEEP...
  29. pmc Circulating markers of interstitial lung disease and subsequent risk of lung cancer
    Meredith S Shiels
    Infections and Immunoepidemiology Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20852, USA
    Cancer Epidemiol Biomarkers Prev 20:2262-72. 2011
    ..Circulating levels of surfactant protein-D (SP-D) and Krebs von Lungren-6 (KL-6) are elevated in interstitial lung disease patients and may be useful markers of processes contributing to lung cancer...
  30. pmc Incidence of breast cancer in the United States: current and future trends
    William F Anderson
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Biostatistics Branch, Executive Plaza South, Rm 8036, 6120 Executive Blvd, Bethesda, MD, USA
    J Natl Cancer Inst 103:1397-402. 2011
    ..Time trends provide important clues for cancer etiology and prevention; however, the observed trends of ER-positive and ER-negative breast cancers can be biased by missing ER data...
  31. pmc Prospective study of genomic hypomethylation of leukocyte DNA and colorectal cancer risk
    Wen Yi Huang
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, EPS 8110, MSC 7240, Bethesda, MD 20892, USA
    Cancer Epidemiol Biomarkers Prev 21:2014-21. 2012
    ..Reduced 5-mC levels in peripheral blood leukocytes have been associated with increased risk of colorectal cancer and adenoma in cross-sectional studies...
  32. pmc Constitutional cytogenetic analysis in men with hereditary testicular germ cell tumor: no evidence of disease-related abnormalities
    Christine M Mueller
    Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, 6120 Executive Boulevard, EPS 7101, Rockville, MD 20852 7231, USA
    Cancer Epidemiol Biomarkers Prev 16:2791-4. 2007
  33. pmc Genomic methylation of leukocyte DNA in relation to colorectal adenoma among asymptomatic women
    Unhee Lim
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Rockville, Maryland, USA
    Gastroenterology 134:47-55. 2008
    ..We examined genomic methylation of leukocyte DNA in relation to colorectal adenoma (CRA) among asymptomatic women (40-79 years of age) participating in a multicenter colonoscopy screening study (CONCeRN Study, 2000-2002)...
  34. pmc Effectiveness of VIA, Pap, and HPV DNA testing in a cervical cancer screening program in a peri-urban community in Andhra Pradesh, India
    Patti E Gravitt
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America
    PLoS ONE 5:e13711. 2010
    ....
  35. ncbi request reprint Hematologic and biochemical changes associated with human T lymphotropic virus type 1 infection in Jamaica: a report from the population-based blood donors study
    Anil K Chaturvedi
    Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20852, USA
    Clin Infect Dis 45:975-82. 2007
    ..Additionally, on a subset of participants, we assessed the epidemiologic relationship of HTLV-1 with Strongyloides stercoralis...
  36. pmc An evaluation by midwives and gynecologists of treatability of cervical lesions by cryotherapy among human papillomavirus-positive women
    Julia C Gage
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20852, USA
    Int J Gynecol Cancer 19:728-33. 2009
    ..To estimate efficacy of a visual triage of human papillomavirus (HPV)-positive women to either immediate cryotherapy or referral if not treatable (eg, invasive cancer, large precancers)...
  37. ncbi request reprint Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40
    Eric A Engels
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD 20892, USA
    J Natl Cancer Inst 95:532-9. 2003
    ..To clarify whether SV40 infection increases risk of these cancers or of cancers arising in children, we examined cancer incidence in three Danish birth cohorts...
  38. doi request reprint 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors
    L Stewart Massad
    Division of Gynecologic Oncology, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Obstet Gynecol 121:829-46. 2013
    ....
  39. doi request reprint 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors
    L Stewart Massad
    Division of Gynecologic Oncology, Washington University School of Medicine, 4911 Barnes Jewish Hospital Plaza, St Louis, MO, USA
    J Low Genit Tract Dis 17:S1-S27. 2013
    ....
  40. pmc Comparison of two expert-based assessments of diesel exhaust exposure in a case-control study: programmable decision rules versus expert review of individual jobs
    Anjoeka Pronk
    Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, Room 8106, MSC 7240, Bethesda, MD 20892 7240, USA
    Occup Environ Med 69:752-8. 2012
    ..To improve transparency and efficiency, we systematically applied decision rules to questionnaire responses to assess diesel exhaust exposure in the population-based case-control New England Bladder Cancer Study...
  41. pmc U.S. geographic distribution of prevaccine era cervical cancer screening, incidence, stage, and mortality
    Marie Josèphe Horner
    Laboratory for Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 8717 Grovemont Circle, Gaithersburg, MD 20892, USA
    Cancer Epidemiol Biomarkers Prev 20:591-9. 2011
    ..To define priority areas for prevention efforts, we examined the geographic distribution of cervical cancer screening, incidence, stage, and mortality in the United States, prior to the introduction of HPV-based prevention technologies...
  42. pmc Nonsteroidal anti-inflammatory drug use and endometrial cancer risk in the NIH-AARP Diet and Health Study
    Kim N Danforth
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health DHHS, 6120 Executive Boulevard, Rockville, MD 20852, USA
    Cancer Prev Res (Phila) 2:466-72. 2009
    ..Overall, our data do not support an association between aspirin or NA-NSAID use and endometrial cancer risk...
  43. pmc Serum cytokine analysis in a positive chemoprevention trial: selenium, interleukin-2, and an association with squamous preneoplastic disease
    Mark J Roth
    Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892 7232, USA
    Cancer Prev Res (Phila) 3:810-7. 2010
    ..The favorable effect of selenomethionine on esophageal dysplasia in the original trial may have been mediated in part by its effect in reducing the levels of IL-2...
  44. pmc Effect of Pap smear collection and carrageenan on cervicovaginal human papillomavirus-16 infection in a rhesus macaque model
    Jeffrey N Roberts
    Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Natl Cancer Inst 103:737-43. 2011
    ..Therefore, we determined whether a cytology specimen collection procedure (Pap smear), which disrupts the epithelium by design, renders the cervix more susceptible to HPV infection in a primate model...
  45. pmc Leisure time physical activity of moderate to vigorous intensity and mortality: a large pooled cohort analysis
    Steven C Moore
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
    PLoS Med 9:e1001335. 2012
    ..Our objective was to determine the years of life gained after age 40 associated with various levels of physical activity, both overall and according to body mass index (BMI) groups, in a large pooled analysis...
  46. pmc The relationship between DNA methylation and telomere length in dyskeratosis congenita
    Shahinaz M Gadalla
    Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20852, USA
    Aging Cell 11:24-8. 2012
    ..17), subtelomeric (r = -0.20) were present in unaffected relatives. This study suggests an interaction between TL and both subtelomeric and LINE-1 methylation, which may be altered based on mutation status of telomere biology genes...
  47. ncbi request reprint Serum high-density lipoprotein cholesterol and risk of non-hodgkin lymphoma
    Unhee Lim
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Rockville, Maryland 20852, USA
    Cancer Res 67:5569-74. 2007
    ..06). Our findings implicate HDL-C as a preclinical indicator of NHL and warrant further prospective investigations for its etiologic contribution...
  48. ncbi request reprint Blood folate levels and risk of liver damage and hepatocellular carcinoma in a prospective high-risk cohort
    Tania M Welzel
    Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, EPS, Bethesda, MD 20892 7234, USA
    Cancer Epidemiol Biomarkers Prev 16:1279-82. 2007
    ..To examine this association in humans, folate levels in blood and risk for subsequent liver damage and hepatocellular carcinoma (HCC) were assessed in a population at high risk of liver cancer in China...
  49. pmc Validity and reliability of exposure assessors' ratings of exposure intensity by type of occupational questionnaire and type of rater
    Melissa C Friesen
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, Bethesda, MD 20892 7240, USA
    Ann Occup Hyg 55:601-11. 2011
    ..Our aim was to identify areas where improvements in exposure assessment may be possible...
  50. ncbi request reprint Effects of a controlled diet and black tea drinking on the fecal microflora composition and the fecal bile acid profile of human volunteers in a double-blinded randomized feeding study
    Volker Mai
    Department of Epidemiology and Preventive Medicine, University of Maryland Medical School, Baltimore, MD 21201, USA
    J Nutr 134:473-8. 2004
    ..Larger studies with well defined end points that control for the observed variation are needed to improve our understanding of the effects of diet on intestinal microflora and fecal bile acid profile...
  51. doi request reprint Epidemiologic analysis of histologic cervical inflammation: relationship to human papillomavirus infections
    Melinda Butsch Kovacic
    Institute for Personalized and Predictive Medicine, Cincinnati Children s Hospital Medical Center, Cincinnati, OH 45229, USA
    Hum Pathol 39:1088-95. 2008
    ..Additional studies are needed to confirm and extend these findings...
  52. ncbi request reprint Limited family structure and breast cancer risk
    Edwin S Iversen
    JAMA 298:2007; author reply 2007-8. 2007
  53. ncbi request reprint Re: All-cause mortality in randomized trials of cancer screening
    Mitchell H Gail
    J Natl Cancer Inst 94:862; author reply 865-6. 2002